These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9786728)

  • 41. Differential effects of fedotozine compared to other kappa agonists on diuresis in rats.
    Soulard CD; Guerif S; Payne A; Dahl SG
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1379-85. PubMed ID: 8968362
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The kappa agonist fedotozine modulates colonic distention-induced inhibition of gastric motility and emptying in dogs.
    Gué M; Junien JL; Buéno L
    Gastroenterology; 1994 Nov; 107(5):1327-34. PubMed ID: 7926497
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Efficacy of sulpiride and itopride in the treatment of functional dyspepsia in women with emotional and eating disorders].
    Wachowska-Kelly P; Walecka-Kapica E; Wojtkiewicz P; Pawłowicz M; Klupińska G; Chojnacki C
    Pol Merkur Lekarski; 2014 Jul; 37(217):39-42. PubMed ID: 25154198
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Peripheral kappa-opioid agonists for visceral pain.
    Rivière PJ
    Br J Pharmacol; 2004 Apr; 141(8):1331-4. PubMed ID: 15051626
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of osteosarcoma-induced thermal hyperalgesia in mice by the orally active dual enkephalinase inhibitor PL37. Potentiation by gabapentin.
    Menéndez L; Hidalgo A; Meana A; Poras H; Fournié-Zaluski MC; Roques BP; Baamonde A
    Eur J Pharmacol; 2008 Oct; 596(1-3):50-5. PubMed ID: 18692494
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prokinetics for the treatment of functional dyspepsia: Bayesian network meta-analysis.
    Yang YJ; Bang CS; Baik GH; Park TY; Shin SP; Suk KT; Kim DJ
    BMC Gastroenterol; 2017 Jun; 17(1):83. PubMed ID: 28651565
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional dyspepsia: the role of visceral hypersensitivity in its pathogenesis.
    Keohane J; Quigley EM
    World J Gastroenterol; 2006 May; 12(17):2672-6. PubMed ID: 16718751
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of fedotozine on human distal colon.
    Adami M; Bertaccini G; Roncoroni L; Cobianchi F
    Ital J Gastroenterol; 1996; 28(8):441-6. PubMed ID: 9032586
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical evaluation of a new hypotensive drug combination].
    Castillo Higueras PL; Rodríguez Cuartero A; Rodríguez Cuartero F; Urbano Jiménez F; Peláez Redondo J
    Rev Clin Esp; 1977 Oct; 147(2):185-9. PubMed ID: 601282
    [No Abstract]   [Full Text] [Related]  

  • 50. Comparison of therapeutic effects of coronary drugs in the USSR.
    Simonson E; Berman R
    Am Heart J; 1971 Nov; 82(5):684-6. PubMed ID: 4940222
    [No Abstract]   [Full Text] [Related]  

  • 51. Synthesis and biological evaluation of the major metabolite of atomoxetine: elucidation of a partial kappa-opioid agonist effect.
    Creighton CJ; Ramabadran K; Ciccone PE; Liu J; Orsini MJ; Reitz AB
    Bioorg Med Chem Lett; 2004 Aug; 14(15):4083-5. PubMed ID: 15225731
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia.
    Hiyama T; Yoshihara M; Matsuo K; Kusunoki H; Kamada T; Ito M; Tanaka S; Nishi N; Chayama K; Haruma K
    J Gastroenterol Hepatol; 2007 Mar; 22(3):304-10. PubMed ID: 17295758
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanical activation of dorsal root ganglion cells in vitro: comparison with capsaicin and modulation by kappa-opioids.
    Gschossmann JM; Chaban VV; McRoberts JA; Raybould HE; Young SH; Ennes HS; Lembo T; Mayer EA
    Brain Res; 2000 Feb; 856(1-2):101-10. PubMed ID: 10677616
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Review article: drugs interfering with visceral sensitivity for the treatment of functional gastrointestinal disorders--the clinical evidence.
    Kuiken SD; Tytgat GN; Boeckxstaens GE
    Aliment Pharmacol Ther; 2005 Mar; 21(6):633-51. PubMed ID: 15771750
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [New painkillers inhibiting the physiological breakdown of endogenous opioids].
    Roques BP; Fournié-Zaluski MC; Wurm M
    Med Sci (Paris); 2012 May; 28(5):476-8. PubMed ID: 22643000
    [No Abstract]   [Full Text] [Related]  

  • 56. Peripheral opioid modulation of visceral pain.
    Gebhart GF; Su X; Joshi S; Ozaki N; Sengupta JN
    Ann N Y Acad Sci; 2000; 909():41-50. PubMed ID: 10911923
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of itopride hydrochloride and ranitidine in patients with functional dyspepsia: comparison between prokinetic and acid suppression therapies.
    Chiba T; Tokunaga Y; Ikeda K; Takagi R; Chishima R; Terui T; Kudara N; Endo M; Inomata M; Orii S; Suzuki K
    Hepatogastroenterology; 2007 Sep; 54(78):1878-81. PubMed ID: 18019739
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The use of prokinetics for the correction of motor and tonic digestive disorders].
    Maev IV; Samsonov AA; Karmanova EA; Ivanchenko EA
    Klin Med (Mosk); 2009; 87(3):49-53. PubMed ID: 19469257
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activation of κ Opioid Receptors in Cutaneous Nerve Endings by Conorphin-1, a Novel Subtype-Selective Conopeptide, Does Not Mediate Peripheral Analgesia.
    Deuis JR; Whately E; Brust A; Inserra MC; Asvadi NH; Lewis RJ; Alewood PF; Cabot PJ; Vetter I
    ACS Chem Neurosci; 2015 Oct; 6(10):1751-8. PubMed ID: 26225903
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cellular mechanism for anti-analgesic action of agonists of the kappa-opioid receptor.
    Pan ZZ; Tershner SA; Fields HL
    Nature; 1997 Sep; 389(6649):382-5. PubMed ID: 9311779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.